Cargando…

On the role of RNA binding proteins in polyglutamine diseases: from pathogenesis to therapeutics

Detalles Bibliográficos
Autores principales:	Conceição, André, Koppenol, Rebekah, Nóbrega, Clévio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358700/ https://www.ncbi.nlm.nih.gov/pubmed/37449627 http://dx.doi.org/10.4103/1673-5374.373711

Ejemplares similares

Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?
por: Marcelo, Adriana, et al.
Publicado: (2021)

PolyQ Database—an integrated database on polyglutamine diseases
por: Estevam, Bernardo, et al.
Publicado: (2023)

Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias
por: Afonso-Reis, Ricardo, et al.
Publicado: (2021)

Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics
por: Paulino, Rodrigo, et al.
Publicado: (2023)

MSGP: the first database of the protein components of the mammalian stress granules
por: Nunes, Catarina, et al.
Publicado: (2019)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility
por: Ryan, Calen P, et al.
Publicado: (2013)

Skeletal Muscle Pathogenesis in Polyglutamine Diseases
por: Marchioretti, Caterina, et al.
Publicado: (2022)

Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies
por: Xiang, Chunchen, et al.
Publicado: (2018)

The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington’s disease
por: Nóbrega, Clévio, et al.
Publicado: (2020)

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
por: Takeuchi, Toshihide, et al.
Publicado: (2017)

Emerging Roles of NANOS RNA-Binding Proteins in Cancer
por: Ilaslan, Erkut, et al.
Publicado: (2022)

RNA-binding proteins modulate drug sensitivity of cancer cells
por: Rogoyski, Oliver, et al.
Publicado: (2021)

The role of viruses in the pathogenesis of Parkinson’s disease
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2020)

The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits
por: Koppenol, Rebekah, et al.
Publicado: (2022)

The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Autophagy and polyglutamine diseases
por: Jimenez-Sanchez, Maria, et al.
Publicado: (2012)

The Emerging Role of microRNAs in Polyglutamine Diseases
por: Dong, Xiaoyu, et al.
Publicado: (2019)

Editorial: The role of posttranslational modifications in polyglutamine diseases
por: Weber, Jonasz Jeremiasz, et al.
Publicado: (2023)

Structure of puromycin-sensitive aminopeptidase and polyglutamine binding
por: Madabushi, Sowmya, et al.
Publicado: (2023)

Nuclear accumulation of polyglutamine disease proteins and neuropathology
por: Havel, Lauren S, et al.
Publicado: (2009)

Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2
por: Afonso, Inês T., et al.
Publicado: (2022)

DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases
por: Zhang, Nan, et al.
Publicado: (2021)

OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
por: Wong, David C. S., et al.
Publicado: (2023)

Structure prediction of polyglutamine disease proteins: comparison of methods
por: Wen, Jingran, et al.
Publicado: (2014)

Editorial: Gene Silencing and Editing Strategies for Neurodegenerative Diseases
por: Nóbrega, Clévio, et al.
Publicado: (2018)

A Helping Hand: RNA-Binding Proteins Guide Gene-Binding Choices by Cohesin Complexes
por: Coyne, Alyssa N., et al.
Publicado: (2016)

Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity
por: Ghosh, Baijayanti, et al.
Publicado: (2021)

Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
por: Minakawa, Eiko N., et al.
Publicado: (2021)

Identification of Novel Therapeutic Targets for Polyglutamine Diseases That Target Mitochondrial Fragmentation
por: Traa, Annika, et al.
Publicado: (2021)

Interferon mediated neuroinflammation in polyglutamine disease is not caused by RNA toxicity
por: Bhambri, Aksheev, et al.
Publicado: (2020)

Immunological role of sulfatide in the pathogenesis of multiple sclerosis
por: Hamatani, Mio, et al.
Publicado: (2023)

A working model for condensate RNA-binding proteins as matchmakers for protein complex assembly
por: Chen, Xiuzhen, et al.
Publicado: (2022)

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
por: Buijsen, Ronald A.M., et al.
Publicado: (2019)

Protein condensation diseases: therapeutic opportunities
por: Vendruscolo, Michele, et al.
Publicado: (2022)

The emerging roles of long non‐coding RNAs in polyglutamine diseases
por: Dong, Xiaoyu, et al.
Publicado: (2021)

Emerging roles for insulin-like growth factor binding protein like protein 1
por: Li, Yingqian, et al.
Publicado: (2019)

Interaction between Gut Microbiota and Celiac Disease: From Pathogenesis to Treatment
por: Rossi, Roberta Elisa, et al.
Publicado: (2023)

Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington’s disease
por: Matlahov, Irina, et al.
Publicado: (2019)

RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis
por: Chan, Ho Yin Edwin
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q2qs1ife9lrtqfkq5slmpvvhth